259 related articles for article (PubMed ID: 36335711)
1. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
3. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
[TBL] [Abstract][Full Text] [Related]
4. Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus.
Anderson EW; Fishbein J; Hong J; Roeser J; Furie RA; Aranow C; Volpe BT; Diamond B; Mackay M
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34686589
[TBL] [Abstract][Full Text] [Related]
5. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
[TBL] [Abstract][Full Text] [Related]
6. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
8. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
[TBL] [Abstract][Full Text] [Related]
9. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
Sun Y; Drevets W; Turecki G; Li QS
Brain Behav Immun; 2020 Jul; 87():404-412. PubMed ID: 31978524
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway changes in late-life depression with memory deficit.
Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
[TBL] [Abstract][Full Text] [Related]
11. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
[TBL] [Abstract][Full Text] [Related]
12. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
Milaneschi Y; Allers KA; Beekman ATF; Giltay EJ; Keller S; Schoevers RA; Süssmuth SD; Niessen HG; Penninx BWJH
Brain Behav Immun; 2021 Oct; 97():167-175. PubMed ID: 34252568
[TBL] [Abstract][Full Text] [Related]
13. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
14. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
15. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder.
Öztürk M; Yalın Sapmaz Ş; Kandemir H; Taneli F; Aydemir Ö
Int J Clin Pract; 2021 Apr; 75(4):e13739. PubMed ID: 32997876
[TBL] [Abstract][Full Text] [Related]
16. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
[No Abstract] [Full Text] [Related]
17. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative analysis of tryptophan and its metabolites in urine by ultra performance liquid chromatography-tandem mass spectrometry].
Li H; Cui L; Zhang G; Zhang M; Jiao L; Wu W
Se Pu; 2021 May; 39(5):518-525. PubMed ID: 34227336
[TBL] [Abstract][Full Text] [Related]
19. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
[TBL] [Abstract][Full Text] [Related]
20. Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome.
Chojnacki C; Błońska A; Konrad P; Chojnacki M; Podogrocki M; Poplawski T
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
